Merendino Lauren
Officer at DAWN; Chief Commercial Officer at Myovant Sciences Ltd.
- Sold, on record
- $343k
- Dollars the filings state
- Form 4 sales
- 8
- Latest Feb 17, 2026
- Form 144 notices
- 3
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- DAWNDay One Biopharmaceuticals, Inc.Officer
- Myovant Sciences Ltd.Chief Commercial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- DAWN17,233 shares
- Myovant Sciences Ltd.12,464 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Myovant Sciences Ltd.Plan not statedJan 18, 2023 2023
Sold 2,008 shares at $26.89 ($54k)
Merendino Lauren, Chief Commercial Officer
Sold 1.2% of holdings ($4.6M position)169,538 shares left1.2x usual sizeFiling
- 2 Form 144 notice DAWNNoticeMay 16, 2025 +849 days
Filed to sell 3,927 shares ($25k)
Merendino Lauren, Officer
No 10b5-1 planFirst sale on recordFiling
- 3 Form 4 sale DAWNNo planMay 16, 2025 same day
Sold 3,927 shares at $6.26 ($25k)
Merendino Lauren, Chief Commercial Officer
No 10b5-1 planSold 10% of holdings ($245k position)35,161 shares leftFirst sale on recordFollows a Form 144Filing
- 4 Form 4 sale DAWNNo planAug 18, 2025 +94 days
Sold 3,766 shares at $6.77 ($25k)
Merendino Lauren, Chief Commercial Officer
No 10b5-1 planSold 8.2% of holdings ($309k position)41,931 shares leftFiling
- 5 Form 144 notice DAWNNoticeNov 17, 2025 +91 days
Filed to sell 3,726 shares ($33k)
Merendino Lauren, Officer
No 10b5-1 planFiling
- 6 Form 4 sale DAWNNo planNov 17, 2025 same day
Sold 3,726 shares at $8.91 ($33k)
Merendino Lauren, Chief Commercial Officer
No 10b5-1 planSold 6.8% of holdings ($486k position)50,809 shares leftFollows a Form 144Filing
- 7 Form 144 notice DAWNNoticeFeb 17, 2026 +92 days
Filed to sell 5,814 shares ($67k)
Merendino Lauren, Officer
No 10b5-1 plan1.5x usual sizeFiling
- 8 Form 4 sale DAWNNo planFeb 17, 2026 same day
Sold 5,814 shares at $11.60 ($67k)
Merendino Lauren, Chief Commercial Officer
No 10b5-1 planSold 8.8% of holdings ($765k position)60,157 shares left1.5x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (11)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Feb 18, 2026 | DAWN | Chief Commercial Officer | Form 4 sale | 5,814 | $67k | 8.8% | No plan | SEC |
| Feb 17, 2026 | Feb 17, 2026 | DAWN | Officer | Form 144 notice | 5,814 | $67k | Notice | SEC | |
| Nov 17, 2025 | Nov 18, 2025 | DAWN | Chief Commercial Officer | Form 4 sale | 3,726 | $33k | 6.8% | No plan | SEC |
| Nov 17, 2025 | Nov 17, 2025 | DAWN | Officer | Form 144 notice | 3,726 | $33k | Notice | SEC | |
| Aug 18, 2025 | Aug 19, 2025 | DAWN | Chief Commercial Officer | Form 4 sale | 3,766 | $25k | 8.2% | No plan | SEC |
| May 16, 2025 | May 19, 2025 | DAWN | Chief Commercial Officer | Form 4 sale | 3,927 | $25k | 10.0% | No plan | SEC |
| May 16, 2025 | May 16, 2025 | DAWN | Officer | Form 144 notice | 3,927 | $25k | Notice | SEC | |
| Jan 18, 2023 | Jan 20, 2023 | Myovant Sciences Ltd. | Chief Commercial Officer | Form 4 sale | 2,008 | $54k | 1.2% | Plan not stated | SEC |
| Oct 18, 2022 | Oct 20, 2022 | Myovant Sciences Ltd. | Chief Commercial Officer | Form 4 sale | 1,703 | $43k | 1.0% | Plan not stated | SEC |
| Jul 18, 2022 | Jul 20, 2022 | Myovant Sciences Ltd. | Chief Commercial Officer | Form 4 sale | 1,704 | $22k | 1.0% | Plan not stated | SEC |
| Apr 19, 2022 | Apr 21, 2022 | Myovant Sciences Ltd. | Chief Commercial Officer | Form 4 sale | 7,049 | $74k | 3.9% | Plan not stated | SEC |